Stockwatch: Get Ready For Pharma's Predictable Half-year Surprises
Executive Summary
It is coming up to half-year results season and two things are entirely predictable: there will be many surprises and hardly any of them will be good.
You may also be interested in...
2017 Pharma Sales: A New Global Order
As the reality of annual results arrive, Scrip predicts how the top of the pharma league table is likely to change.
Gender Diversity In Pharma: Caught Between Desire And Reality
Charting the executive gender mix across 384 companies from mid-2014 to mid-2019 demonstrates that C-suite gender balance in pharma is moving towards a point that more closely reflects its total workforce, but that progress has been slow and that there is a long road to travel before the transformation is complete.
Women In High Places: Slow Progress In Pharma
With gender diversity only slowly increasing in biopharma c-suites, Scrip spoke to executives from five companies about the importance of change.